Ahmed Mousa

Biotech entrepreneur, CEO of Vicore Pharma | Molecular and computational bio @Cornell, @JohnsHopkins, IP @GeorgetownLaw | Husband and green egg enthusiast

[Ahmed Mousa @asmousa]

@Frank_S_David @henrylindavid Excited to get a copy of this for my nephew!

[Omar Abudayyeh @omarabudayyeh]

Super thrilled to see @Tome_bio come out of stealth to translate the vision of programmable gene replacement as a new editing modality for genomic medicines and cell therapy. Started this company with @jgooten to solve challenges in the gene therapy and gene editing fields. 🧵👇

[Ahmed Mousa @asmousa]

@angelosgeo Congratulations, @angelosgeo ! Looking forward to reading it.

[Pareto Securities AB @ParetoSecSE]

Tomorrow, we host our annual Healthcare Conference for the 14th year in a row. Vicore Pharma’s new CEO Ahmed Mousa, could unfortunately not attend, but we had a chat with him instead. $VICO

https://t.co/dWXur4Bj6d

[Ahmed Mousa @asmousa]

Great update from @PierisPharma at @atscommunity today: Our R&D team is presenting at #ATS2023 on PRS-220, our inhaled CTGF program that's outperformed systemic antibody pamrevlumab in a lung fibrosis mouse model. A major leap in localized interventions. #IPF

[Ahmed Mousa @asmousa]

Excited to be part of @atscommunity, showcasing the latest in the @PierisPharma's inhaled pipeline at RIS. Today CDO Shane Olwill presented on PRS-220, our novel inhaled CTFG antagonist in the 'Innovators in Fibrosis' set. Can't wait for more insightful exchanges at #ATS2023.

[Presidential Leadership Scholars @PLSprogram]

NEW TODAY: Applications are now open to join the #PLScholars Class of 2024! Join a diverse network of change-makers and explore leadership lessons from the presidential experiences of George W. Bush, Bill Clinton, George H.W. Bush, and Lyndon B. Johnson: https://t.co/Gk9poj9Zvy

[Ahmed Mousa @asmousa]

🚀 Exciting news from @PierisPharma! Cinrebafusp alfa shows promising initial results in 2L+ HER2+ gastric cancer at #AACR2023. Excited to see the potential of our Anticalin tech & 4-1BB franchise in transforming cancer treatment! 🧪🔬https://t.co/Q3ioV5gMAm

[Presidential Leadership Scholars @PLSprogram]

The 2023 #PLScholars convened at @TheBushCenter in late March to learn about decision making through the lens of President George W. Bush’s leadership. Take a look at some of our favorite Module Three moments here: https://t.co/TOaVE5GXNV

[Ahmed Mousa @asmousa]

Excited to see my friend @pervezagwan announce his run for Congress. Those who know Pervez admire his passion for the social justice, equitable access to healthcare, and environmental protection--he'll be an incredible advocate for #TX07 and US Representative!

[Clinton Presidential Center @ClintonCenter]

Hi #PLScholars 👋, welcome to Little Rock! We are thrilled to host you at the Clinton Center. @PLSprogram

[Clinton Presidential Center @ClintonCenter]

This week we're welcoming the #PLScholars to Little Rock. Meet the @PLSprogram class of 2023: https://t.co/bTViBxPkB6

[Ahmed Elnaggar @Elnaggar_AI]

Introducing Ankh ☥ :
An optimized protein language model (PLM) achieving SoTA performance with < 10% of the top/closest-performing models’ parameters. It is benchmarked on various downstream protein tasks, and tested for protein generation.
https://t.co/7VYwz748TV
(1/n)

[Noha A. Sherif @_nohasherif]

Eternally proud and in awe of my kind, brilliant husband @asmousa who was selected amongst the 2023 Presidential Leadership Scholars!
https://t.co/RO8aIBjdsB via @PLSprogram #PLS

[Palvella Therapeutics @PalvellaTX]

Thrilled to share an important clinical alliance milestone within the Pieris 4-1BB franchise: first person dosed by our partner with CD228 x 4-1BB bispecific Mabcalin™ compound! Read the announcement here: https://t.co/mQYfl08HXt

[Ahmed Mousa @asmousa]

Proud to share that @PierisPharma has initiated clinical development of our anti-CTGF program for IPF, PRS-220. IPF is a terrible disease and we look forward to advancing a therapy that we believe has the potential for meaningful impact on patients. https://t.co/AtYvsIyG4i

[Demis Hassabis @demishassabis]

A year ago we open-sourced #AlphaFold

Today we're freely sharing the predicted structures of all 200M+ proteins known to science - almost the entire protein universe!

It's our gift to humanity, and a demonstration of the benefits AI can bring to society
https://t.co/G8vj8sbTcN

[Mohammed AlQuraishi @MoAlQuraishi]

We have successfully trained OpenFold from scratch, our trainable PyTorch implementation of AlphaFold2. The new OpenFold (OF) (slightly) outperforms AlphaFold2 (AF2). I believe this is the first publicly available reproduction of AF2. We learned a lot. A🧵1/12

[Ahmed Mousa @asmousa]

Kicking off #bio2022 in San Diego. Looking forward to a productive week with the @PierisPharma team!

[Ahmed Mousa @asmousa]

Gun violence is a public health issue. Glad the biotech industry is stepping up to advocate for change and proud to co-sign this letter.

[Peter Kolchinsky @PeterKolchinsky]

The biomedical industry can’t invent a medicine for gun violence, and yet we can’t avert our eyes from the deaths or just stand by, so we write…

Please read our letter calling for reforms, an initiative led by @daphnezohar, and consider signing on.

https://t.co/67mglkUzqI